CSL — full event log
Every event we have on file across every reporting year. The Data-by-year tab summarises the top 10 per year; this page shows them all.
← back to Data by year2024· 11 events
CSL has set an SBTi-aligned absolute reduction target of Scope 1 and Scope 2 GHG emissions by 40% against a baseline of average annual emissions FY19-21. Also intends for suppliers accounting for 67% of Scope 3 emissions to set Scope 1&2 SBTi-aligned targets.
sustainability_report p.4
CSL's Scope 1 emissions increased slightly due to a change in methodology for refrigerants, where more accurate data was now available.
sustainability_report p.4
CSL has set a target to achieve zero percent absolute growth in water use, against FY2021 baseline, at three priority manufacturing sites (Kankakee, Broadmeadows, Tullamarine) located in regions forecast to be water stressed by 2030.
sustainability_report p.4
By 2030, CSL aims to divert more than 90% of manufacturing waste from landfill ('Zero Waste' at all manufacturing sites), reduce % waste to landfill year on year at plasma collection centres, and minimise % of waste incinerated.
sustainability_report p.4
Updated gender goals: People Manager by FY25 (min 45% women / min 45% men / 10% nonbinary or not disclosed); Senior Executive by FY30 (min 40% women / min 40% men / 20% nonbinary or not disclosed).
sustainability_report p.2
CSL aims by 2030 for 50% of its supply base (by spend) to have publicly available inclusion and belonging policies that promote respect and diversity of thought or provide diverse teams.
sustainability_report p.2
CSL is investing in renewable electricity and improving facility energy efficiency. Australian manufacturing sites will transition to renewable electricity from January 2025. Increased renewable electricity use across the CSL enterprise was the key driver of decreased Scope 2 emissions in FY24, despite production returning to pre-COVID levels.
sustainability_report p.4
CSL is reducing direct operational emissions by improving energy efficiency of facilities and designing/building new facilities with sustainability in mind. Despite facility expansions and return to pre-COVID production levels, total Scope 1+2 emissions have remained relatively stable.
sustainability_report p.4
Investment in renewable electricity is a central lever, anchored by the transition of Australian manufacturing sites to renewable electricity from January 2025. This is cited as a primary driver of Scope 2 reductions.
sustainability_report p.4
CSL has actively engaged with 71.3% of suppliers by emissions to set SBTi-aligned targets; 51.7% of suppliers (by share of FY23 Scope 3 emissions) have self-reported Scope 1&2 SBTi-aligned targets. CSL intends for suppliers accounting for 67% of Scope 3 emissions to set such targets.
sustainability_report p.4
CSL improved data accuracy on refrigerants in FY24, which slightly increased reported Scope 1 emissions. Refrigerants are a meaningful direct-emissions lever for pharmaceutical manufacturing operations.
sustainability_report p.4